KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 156 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 4.14 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,185,630 | +258.3% | 662,363 | +580.5% | 0.00% | – |
| Q4 2022 | $330,943 | +308.6% | 97,336 | +559.1% | 0.00% | – |
| Q3 2022 | $81,000 | -91.4% | 14,768 | -92.9% | 0.00% | – |
| Q2 2022 | $941,000 | -81.8% | 208,597 | -70.3% | 0.00% | -100.0% |
| Q1 2022 | $5,169,000 | +123.2% | 701,443 | +94.8% | 0.00% | – |
| Q4 2021 | $2,316,000 | +442.4% | 360,143 | +391.1% | 0.00% | – |
| Q3 2021 | $427,000 | -35.4% | 73,328 | +14.5% | 0.00% | – |
| Q2 2021 | $661,000 | -46.4% | 64,042 | -45.4% | 0.00% | – |
| Q1 2021 | $1,233,000 | -59.4% | 117,225 | -40.3% | 0.00% | -100.0% |
| Q4 2020 | $3,039,000 | +50.5% | 196,358 | +42.0% | 0.00% | +100.0% |
| Q3 2020 | $2,019,000 | -63.0% | 138,325 | -52.0% | 0.00% | -80.0% |
| Q2 2020 | $5,457,000 | +111.7% | 288,119 | +114.7% | 0.01% | +66.7% |
| Q1 2020 | $2,578,000 | +801.4% | 134,200 | +798.4% | 0.00% | – |
| Q4 2019 | $286,000 | +38.8% | 14,937 | -30.3% | 0.00% | – |
| Q3 2019 | $206,000 | -68.7% | 21,423 | +51.6% | 0.00% | -100.0% |
| Q2 2014 | $658,000 | – | 14,132 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Delphi Management Partners VIII, L.L.C. | 2,263,006 | $13,170,000 | 9.51% |
| Palo Alto Investors LP | 5,383,052 | $31,329,000 | 1.89% |
| Birchview Capital, LP | 246,000 | $1,432,000 | 0.97% |
| Rubric Capital Management LP | 3,375,758 | $19,647,000 | 0.55% |
| Lombard Odier Asset Management (Switzerland) SA | 1,517,804 | $8,834,000 | 0.55% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,401,861 | $8,159,000 | 0.30% |
| AlphaCentric Advisors LLC | 136,000 | $792,000 | 0.20% |
| Bridgefront Capital, LLC | 20,946 | $122,000 | 0.13% |
| Hennion & Walsh Asset Management, Inc. | 407,474 | $2,371,000 | 0.12% |
| Virtus ETF Advisers LLC | 44,364 | $258,000 | 0.11% |